Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02607917 · ClinicalTrials.gov registry record · NA
Testing a Community Intervention to Increase Aspirin Use
A NA study of Stroke and Myocardial Infarction, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 10,800
- Enrollment target
- 1
- Study location
NCT02607917: Completed NA study of Stroke and Myocardial Infarction, sponsored by University of Minnesota.
NCT02607917 is a NA study of Stroke and Myocardial Infarction that has completed, run by University of Minnesota. The registered enrollment target is 10,800 participants, below the 11,993-participant average among 454 other Stroke trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02607917, a NA study of Stroke and Myocardial Infarction, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 10,800 participants
- Enrollment target
- 1
- Study location
Study Summary
This research will test the effect of mass media or mass media plus a clinic based education program will improve appropriate aspirin use for cardiovascular disease prevention. It is a group randomized design of 24 geographic areas in Minnesota with adjacent states serving as controls.
Primary Outcome
Aspirin use will be determined by standardized surveys of randomly selected adults.
Conditions Studied
Interventions
- OTHER Mass Media plus clinic intervention.
- OTHER Media
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,800 participants |
| Start Date | 2015-02-16 |
| Est. Completion | 2020-07-01 |
| Phase | NA |
What the finished NCT02607917 record still lists
NCT02607917 is an interventional study that assigns participants to a tested intervention. Its 10,800 participants enrollment target places it among the larger protocols in the corpus, below the 11,993-participant average among 454 other Stroke trials with a reported enrollment target (10% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Mass Media plus clinic intervention. is the first listed.
NCT02607917 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02607917 about?
NCT02607917 is a clinical study titled "Testing a Community Intervention to Increase Aspirin Use". This research will test the effect of mass media or mass media plus a clinic based education program will improve appropriate aspirin use for cardiovascular disease prevention. It is a group randomized design of 24 geographic areas in Minnesota with adjacent states serving as controls.
What is the current status of trial NCT02607917?
This trial is currently completed. It is a NA study. The enrollment target is 10,800 participants. The study started on 2015-02-16. Estimated completion is 2020-07-01.
What conditions does trial NCT02607917 study?
This clinical trial studies the following conditions: Stroke, Myocardial Infarction.
What interventions are being tested in trial NCT02607917?
The interventions under investigation include: Mass Media plus clinic intervention. (OTHER), Media (OTHER).
Who is sponsoring clinical trial NCT02607917?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02607917 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02607917's enrollment target sits among peer trials
10,800 9th of 454 higher than 446 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06468202 · 10,742 participants · Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
- NCT06736951 · 10,890 participants · NA
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI